Work

Development of novel benzo[ d ][1,2,3]triazole-acetohydrazone derivatives as potential therapeutic agents: synthesis, SAR study, inhibition of carbohydrate metabolism enzymes, and aldose reductase supported by molecular modelling simulation

Year: 2026
Type: article
Abstract: ). Consequently, compound 11 holds promise as a lead molecule for developing novel therapeutic agents targeting α-amylase, α-glucosidase, and aldose reductase for diabetes management. Furthermore, molecular docking and molecular dynamics simulations (100 ns) elucidated stable interactions between compound 11 and the catalytic pockets of both α-amylase and α-glucosidase, primarily mediated by hydrogen bonding and hydrophobic interactions. The ADME analysis revealed an acceptable physicochemical profile, characterized by good aqueous solubility and a minimal predicted risk of CYP-mediated drug-drug interaction. Finally, these findings indicate that benzotriazole derivative 11 may serve as a promising scaffold for further optimization toward a multi-target anti-diabetic drug development agent.
Source: RSC Advances
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7234994245
FWCI:
Cites: 67
Cited by:
Related to: 10